Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Radiation Oncology Program

University Hospitals Seidman Cancer Center

Key Contacts

Lauren Allyn, Department Administrator |  216-286-4144

Appointment Line

Please call 440-745-7488. For the UH Proton Therapy Center, please call 855-548-9117.
For hospital transfers, please call 216-844-1111.

Conditions Treated

  • All malignant neoplasms
  • Several types of benign neoplasms, particularly those located in the brain and/or spine
  • Selected “benign” diseases of the brain, including arteriovenous malformations, trigeminal neuralgia and refractory essential tremor

Therapies

  • Proton beam radiation therapy
  • Gamma Knife® stereotactic radiosurgery (fixed frame brain treatment)
  • Linac-guided radiosurgery
  • Full range of image-guided, intensity-modulated radiation therapy (IGRT/IMRT) procedures 
  • Full range of brachytherapy procedures (high-dose rate or low-dose rate)
  • Highly complex gynecologic and genitourinary brachytherapy, including multiparametric MRI image guidance
  • Re-irradiation for selected patients who have already received radiation to the same area

Distinguishing Features

  • 2,000 patients treated with radiosurgery since 2008
  • First Proton Therapy Center in Ohio, located adjacent to UH Rainbow Babies & Children’s Hospital and UH Seidman Cancer Center, fostering seamless, multidisciplinary care
  • Subspecialist radiation oncologists nationally recognized for their expertise in organ/disease site, including CNS/brain, lung/thoracic, breast, genitourinary/gynecologic, gastrointestinal and hematologic/pediatric
  • Advanced techniques for cardiac-sparing radiation therapy for patients with breast cancer and other thoracic neoplasms (lung, thymus, esophagus, lymphoma)
  • Extensive clinical trials, including leadership in national NCI-sponsored protocols (RTOG/NRG) and UH investigator-initiated in-house, early-phase trials
  • Among the top-accruing clinical trials centers in the nation